ONCY

ONCOLYTICS BIOTECH INC

Pharmaceutical PreparationsNasdaqAccelerated filer

Total Trades

10

Buys

10

Sells

0

Largest Trade

$100K–$500K

Insiders

9

Institutional Funds

50

Inst. Value

$1M+

Activist Filings

2

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Kelly JaredCEOBUY$15K–$50K35K$0.84Feb 13, 2026
Look KirkCFOBUY$1K–$15K12K$0.84Feb 13, 2026
Pisano WayneDirectorBUY$15K–$50K30K$0.84Feb 13, 2026
Heineman Thomas CharlesChief Medical Offi…BUY$1K–$15K12K$0.83Feb 13, 2026
Brown Deborah MargaretDirectorBUY$15K–$50K25K$0.85Feb 13, 2026
Hagerman AllisonVPBUY$1K–$15K10K$0.83Feb 13, 2026
Seizinger Bernd R.DirectorBUY$50K–$100K100K$0.83Feb 13, 2026
Aromando AndrewChief Business Off…BUY$15K–$50K30K$0.86Feb 13, 2026
Andrews Patricia SDirectorBUY$15K–$50K35K$0.86Feb 13, 2026
Seizinger Bernd R.DirectorBUY$100K–$500K100K$1.04Jan 20, 2026
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 50 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Anson Funds Management LP

SC 13G/A · Nov 14, 2025

7.0%

7.6M shares

Anson Funds Management LP

SC 13G · Feb 14, 2025

9.6%

8.2M shares

View on Google Finance →